These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 9009951
21. N-(3,5-dichlorophenyl)succinimide nephrotoxicity: evidence against the formation of nephrotoxic glutathione or cysteine conjugates. Rankin GO, Shih HC, Teets VJ, Yang DJ, Nicoll DW, Brown PI. Toxicology; 1991; 68(3):307-25. PubMed ID: 1680251 [Abstract] [Full Text] [Related]
22. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Eger EI, Gong D, Koblin DD, Bowland T, Ionescu P, Laster MJ, Weiskopf RB. Anesth Analg; 1997 Nov; 85(5):1154-63. PubMed ID: 9356118 [Abstract] [Full Text] [Related]
23. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. Townsend DM, Hanigan MH. J Pharmacol Exp Ther; 2002 Jan; 300(1):142-8. PubMed ID: 11752109 [Abstract] [Full Text] [Related]
24. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison. Kharasch ED, Jubert C. Anesthesiology; 1999 Nov; 91(5):1267-78. PubMed ID: 10551576 [Abstract] [Full Text] [Related]
25. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Iyer RA, Anders MW. Anesthesiology; 1996 Dec; 85(6):1454-61. PubMed ID: 8968194 [Abstract] [Full Text] [Related]
26. Renal toxicity with sevoflurane: a storm in a teacup? Gentz BA, Malan TP. Drugs; 2001 Dec; 61(15):2155-62. PubMed ID: 11772127 [Abstract] [Full Text] [Related]
27. Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line. Altuntas TG, Zager RA, Kharasch ED. Toxicol Appl Pharmacol; 2003 Nov 15; 193(1):55-65. PubMed ID: 14613716 [Abstract] [Full Text] [Related]
28. Protection from 1-cyano-3,4-epithiobutane nephrotoxicity by aminooxyacetic acid and effect on xenobiotic-metabolizing enzymes in male Fischer 344 rats. VanSteenhouse JL, Prescott JS, Swenson DH. J Appl Toxicol; 1999 Nov 15; 19(4):237-49. PubMed ID: 10439337 [Abstract] [Full Text] [Related]
29. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Goldberg ME, Cantillo J, Gratz I, Deal E, Vekeman D, McDougall R, Afshar M, Zafeiridis A, Larijani G. Anesth Analg; 1999 Feb 15; 88(2):437-45. PubMed ID: 9972771 [Abstract] [Full Text] [Related]
31. Nephrotoxicity of 2-bromo-(cystein-S-yl) hydroquinone and 2-bromo-(N-acetyl-L-cystein-S-yl) hydroquinone thioethers. Monks TJ, Jones TW, Hill BA, Lau SS. Toxicol Appl Pharmacol; 1991 Nov 15; 111(2):279-98. PubMed ID: 1957313 [Abstract] [Full Text] [Related]
32. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants. Monks TJ, Highet RJ, Lau SS. Mol Pharmacol; 1988 Oct 15; 34(4):492-500. PubMed ID: 3173333 [Abstract] [Full Text] [Related]
33. Role of glutathione in acute N-(3,5-dichlorophenyl) succinimide-induced nephrotoxicity in Sprague-Dawley and Fischer 344 rats. Yang DJ, Teets VJ, Bolton B, Brown PI, Rankin GO. Toxicology; 1987 Jul 15; 45(1):25-44. PubMed ID: 3603574 [Abstract] [Full Text] [Related]
34. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Eger EI, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB. Anesth Analg; 1997 Jan 15; 84(1):160-8. PubMed ID: 8989018 [Abstract] [Full Text] [Related]
35. Studies of the mechanism of nephrotoxicity of compound A in rats. Martin JL, Kandel L, Laster MJ, Kerschmann RL, Eger EI. J Anesth; 1997 Mar 15; 11(1):32-37. PubMed ID: 28921267 [Abstract] [Full Text] [Related]
36. Acetaminophen nephrotoxicity in the CD-1 mouse. II. Protection by probenecid and AT-125 without diminution of renal covalent binding. Emeigh Hart SG, Wyand DS, Khairallah EA, Cohen SD. Toxicol Appl Pharmacol; 1996 Jan 15; 136(1):161-9. PubMed ID: 8560470 [Abstract] [Full Text] [Related]
37. Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells. Chen JC, Stevens JL, Trifillis AL, Jones TW. Toxicol Appl Pharmacol; 1990 May 15; 103(3):463-73. PubMed ID: 2339419 [Abstract] [Full Text] [Related]
38. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane. Jin L, Davis MR, Kharasch ED, Doss GA, Baillie TA. Chem Res Toxicol; 1996 Mar 15; 9(2):555-61. PubMed ID: 8839062 [Abstract] [Full Text] [Related]
39. Renal cysteine conjugate beta-lyase and compound A nephrotoxicity: minimal evidence for an association. Njoku DB, Martin JL, Pohl LR. Anesthesiology; 1999 Mar 15; 90(3):921-2. PubMed ID: 10078700 [No Abstract] [Full Text] [Related]
40. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase. Stevens JL, Hatzinger PB, Hayden PJ. Drug Metab Dispos; 1989 Mar 15; 17(3):297-303. PubMed ID: 2568912 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]